Another successful week for ArgusEye during TESTA Challenge 2022
During March 14 – April 1, ArgusEye participated in the second edition of TESTA Challenge in Uppsala. This event is organized by TESTA Center in […]
ArgusEye selected for TESTA Challenge 2022
ArgusEye has again been selected to participate in TESTA Challenge hosted by TESTA Center in Uppsala, Sweden. This is the second edition of TESTA Challenge […]
ArgusEye completes oversubscribed seed funding round
ArgusEye has successfully completed its first external financing round, securing additional funding for further product development and team expansion. The strong investor syndicate in this […]
A successful week for ArgusEye during TESTA Challenge 2020
During October 19-23, ArgusEye participated in TESTA Challenge in Uppsala. This is a new initiative organized by TESTA Center, STUNS and Cytiva. The objective is […]
ArgusEye selected for TESTA Challenge 2020
ArgusEye has been selected to participate in TESTA Challenge 2020 hosted by TESTA Center in Uppsala, Sweden TESTA Challenge is a new initiative organized by […]
ArgusEye at NLS Days 2019, September 10-12
ArgusEye’s CEO Dr. Erik Martinsson will participate at the Nordic Life Science Days 2019 Nordic Life Science Days 2019 will take place on September 10-12 […]
ArgusEye receives new grant from Vinnova
In tough competition with other innovative start-up companies, ArgusEye is granted 900 000 SEK from Vinnova’s program Innovative Startups Step 2. In September 2017, ArgusEye received […]
ArgusEye is granted 500 000 SEK from Vinnova
ArgusEye AB is granted 500 000 SEK from Vinnova’s Runner Up program for the project ”ArgusEye – driving the revolution in manufacturing of biopharmaceuticals”. ArgusEye obtained […]